Methods |
Design: three group parallel trial
Purpose: study the effect of naltrexone for alcohol dependence |
Participants |
Patients: outpatients with alcohol dependence
Baseline comparability: yes (age, gender) |
Interventions |
Placebo: NS (12 weeks)
Untreated: no placebo or naltrexone
Experimental: naltrexone
(Co‐intervention: various individual or group programs) |
Outcomes |
Alcohol consumption (time line follow‐back: average drinks per day, percent days drinking, drinks per drinking days, heavy drinking days)
Percentage with at least one heavy drinking episode
Craving (obsessive compulsive drinking scale)
Various explorative analyses |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Adequate sequence generation? |
Low risk |
urn randomisation |
Allocation concealment? |
Unclear risk |
NS |
Blinding?
Treatment provider |
Unclear risk |
NS |
Blinding?
Outcome assessor |
Unclear risk |
NS |
Incomplete outcome data addressed?
All outcomes |
High risk |
Drop‐out > 15% or NS |
Free of selective reporting? |
Unclear risk |
No protocol available |
Free of other bias? |
Low risk |
|
No signs of variance inequality or skewness? |
Unclear risk |
Not relevant (not naturally positive continuous outcomes e.g. change) |
Trial size > 49? |
Low risk |
N = 59 |
Clearly concealed allocation + trial size > 49 + drop‐out max 15% |
High risk |
Drop‐out > 15% or NS |